IQVIA HOLDINGS INC. (IQV) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Research & Development Solutions	7,556.0	5,760.0	5,788.0	5,465.0	5,105.0		3,159.0	3,050.0
Technology & Analytics Solutions	5,534.0	4,858.0	4,486.0	4,137.0	3,682.0
Contract Sales & Medical Solutions	784.0	741.0	814.0	810.0	915.0
Other							2,578.0	2,410.0
Total revenues [+]	13,874.0	11,359.0	11,088.0	10,412.0	9,702.0	6,815.0	5,737.0	5,460.0
Services							4,326.0	4,165.0
Reimbursements							1,411.0	1,295.0
Revenue growth [+]	22.1%	2.4%	6.5%	7.3%	42.4%	18.8%	5.1%	7.1%
Research & Development Solutions	31.2%	-0.5%	5.9%	7.1%			3.6%
Technology & Analytics Solutions	13.9%	8.3%	8.4%	12.4%
Contract Sales & Medical Solutions	5.8%	-9.0%	0.5%	-11.5%
Cost of goods sold [+]	9,233.0	7,500.0	7,300.0	6,746.0	6,301.0	4,748.0	4,116.0	3,959.0
Cost of services							2,705.0	2,664.0
Reimbursable costs							1,411.0	1,295.0
Cost of services, excluding D&A							2,705.0	2,664.0
Gross profit	4,641.0	3,859.0	3,788.0	3,666.0	3,401.0	2,067.0	1,621.0	1,501.0
Gross margin	33.5%	34.0%	34.2%	35.2%	35.1%	30.3%	28.3%	27.5%
Selling, general and administrative	1,964.0	1,789.0	1,734.0	1,716.0	1,622.0	1,016.0	815.0	781.0
Equity in earnings	6.0	7.0	-9.0	15.0	10.0	-4.0	8.0	-5.0
EBITDA [+]	2,683.0	2,077.0	2,045.0	1,965.0	1,789.0	1,047.0	814.0	715.0
EBITDA growth	29.2%	1.6%	4.1%	9.8%	70.9%	28.6%	13.8%	22.2%
EBITDA margin	19.3%	18.3%	18.4%	18.9%	18.4%	15.4%	14.2%	13.1%
Depreciation	147.0	134.0	128.0	125.0	125.0	79.0	61.0	63.0
EBITA	2,536.0	1,943.0	1,917.0	1,840.0	1,664.0	968.0	753.0	652.0
EBITA margin	18.3%	17.1%	17.3%	17.7%	17.2%	14.2%	13.1%	11.9%
Amortization of intangibles	1,117.0	1,153.0	1,074.0	1,016.0	886.0	210.0	67.0	58.0
EBIT [+]	1,419.0	790.0	843.0	824.0	778.0	758.0	686.0	594.0
EBIT growth	79.6%	-6.3%	2.3%	5.9%	2.6%	10.5%	15.5%	24.4%
EBIT margin	10.2%	7.0%	7.6%	7.9%	8.0%	11.1%	12.0%	10.9%
Non-recurring items [+]	20.0	52.0	75.0	68.0	103.0	186.0	32.0	9.0
Asset impairment					40.0	28.0	2.0
Interest expense, net [+]	369.0	410.0	438.0	406.0	339.0	140.0	97.0	97.0
Interest expense	375.0	416.0	447.0	414.0	346.0	144.0	101.0	101.0
Interest income	6.0	6.0	9.0	8.0	7.0	4.0	4.0	4.0
Other income (expense), net [+]	98.0	45.0	22.0	-22.0	-42.0	-16.0	-18.0	13.0
Gain (loss) on debt retirement	-26.0	-13.0	-24.0	-2.0	-19.0	-31.0	-8.0
Other	130.0	65.0	37.0	-5.0	-13.0	11.0	-2.0	8.0
Pre-tax income	1,128.0	373.0	352.0	328.0	294.0	416.0	539.0	501.0
Income taxes	163.0	72.0	116.0	59.0	-992.0	325.0	159.0	149.0
Tax rate	14.5%	19.3%	33.0%	18.0%		78.1%	29.5%	29.7%
Minority interest	5.0	29.0	36.0	25.0	19.0	15.0	1.0
Net income	966.0	279.0	191.0	259.0	1,277.0	72.0	387.0	357.0
Net margin	7.0%	2.5%	1.7%	2.5%	13.2%	1.1%	6.7%	6.5%

Basic EPS [+]	$5.05	$1.46	$0.98	$1.27	$5.86	$0.48	$3.15	$2.79
Growth	246.1%	49.0%	-23.0%	-78.3%	1114.2%	-84.7%	12.8%	52.8%
Diluted EPS [+]	$4.95	$1.43	$0.96	$1.24	$5.74	$0.47	$3.08	$2.72
Growth	246.2%	49.5%	-23.1%	-78.3%	1111.1%	-84.6%	13.2%	53.7%


Shares outstanding (basic) [+]	191.4	191.3	195.1	203.7	217.8	149.1	123.0	128.0
Growth	0.1%	-1.9%	-4.2%	-6.5%	46.1%	21.2%	-3.9%	3.1%
Shares outstanding (diluted) [+]	195.0	195.0	199.6	208.2	222.6	152.0	125.6	131.1
Growth	0.0%	-2.3%	-4.1%	-6.5%	46.4%	21.0%	-4.2%	2.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.